Constraint · 01
Compressed Timelines
Only 1–2 days allocated to feasibility and strategy — forcing teams to rely on instinct over intelligence.
1–2days for strategy, out of a 10-day window
Better decisions, not perfect predictions.
The Operating System for Clinical Development
Aurora Analytica™ transforms compressed 7–10 day proposal cycles into AI-assisted decision workflows — enabling CROs to design stronger bids, validate strategy, and win more trials.
Days → HoursFeasibility prep time
2 daysRFP to strategy
NPS 10Net Promoter Score
550K+Trial records
The Problem
Clinical trials are won before they begin — but most teams are flying blind.
Inside the typical 10-day RFP window, feasibility and strategy get squeezed into a fraction of the time — and the consequences are enormous.
The 10-day RFP cycle
RFP IntakeDay 1< 1 day
Bottleneck
Feasibility StrategyDay 2–31–2 days
Budget ReviewDay 4–85 days
ProposalDay 8–103 days
Constraint · 02
Fragmented Data
Multiple registries, internal databases, and trial files reconciled manually in spreadsheets under deadline pressure.
7+data sources reconciled manually per proposal
Constraint · 03
Massive Execution Risk
A single missed Tier 1 award represents enormous lost contract value — and faulty assumptions compound post-award.
Tier 1a single missed award compounds post-award
The Aurora Suite™
One Platform. Complete Intelligence.
Six core decision engines, plus an orchestration and enablement layer that ties the whole platform together.
Core Decision Engines
Six modules across two layers — the data foundation, and the analytics engines that act on it.
Database + Analytics
MVP
Trial Core™
The clinical intelligence foundation. 550K+ trial records across 7+ integrated directories, AI-enriched and analysis-ready in hours instead of days.
Released
Plume™
Dynamic intelligence database. User-uploaded datasets and Aurora-internalised public-domain data, available across every module.
MVP
Patient Xplore™
Patient journey, standard-of-care, and reimbursement mapping. Validation-layered synthesis with evidence tags and confidence ratings on every claim.
Analytics
Released
Simulator-L™
Monte Carlo enrolment and timeline simulator. Replaces static spreadsheet timelines with probability distributions — quantifying execution risk before capital is committed.
Released
Geo Matrix™
360° country and site strategy. The proprietary EKO™ ranking algorithm turns feasibility inputs into auditable, study-specific country tiers in minutes, not days.
Released
Simulator-C™
Multi-cohort trial design canvas. Drag-and-drop study composition with auto-derived timelines for basket, umbrella, adaptive, and dose-escalation trials.
Orchestration & Enablement
The intelligence, governance, and platform services that tie every module together.
Q4 2026Integrated across Aurora Suite™
Orchestration Layer
Starlite AI™
The autonomous AI orchestration layer — coordinating workflows across the entire Aurora Suite, accelerating access to insights and trends, and helping teams leverage the full platform without manual orchestration between modules.
Autonomous ReasoningMulti-Module OrchestrationZero-Touch FeasibilityProposal-Ready OutputSelf-Improving Intelligence
Released
Aurora Intel™
Organisational backboneThe organisational backbone, providing secure, versioned project workspaces with audit trail and document intelligence for every clinical development project.
Supporting platform services
Aurora Admin™User managementReleased
Starlite-Flow™Workflow automationReleased
Shared brand kitsPresentation layerReleased
Report builderPresentation layerReleased
The user, security, and presentation layer beneath every module.
Live PreviewTrial Core™ Explorer
Search 550K+ Trials
Search any disease area to see live trial intelligence from the Trial Core™ database.
Results
Proof That Changes Minds
Real results from real deployments. Aurora Analytica™ is measured by the outcomes it delivers.
10/10
Client Satisfaction
Global CRO data intelligence teams rated Aurora 10/10 for overall experience and likelihood to recommend.
2 Days
RFP to Strategy
Aurora compresses the typical 7–10 day feasibility cycle into 48 hours of structured, AI-assisted strategy.
ESMO
Published
AI-driven feasibility methodology peer-reviewed and presented at one of the world's leading oncology conferences.
550K+
Trial Records
The Trial Core™ database aggregates over 550,000 trial records from 7+ global directories — the world's most comprehensive clinical intelligence foundation.
EIC
Accelerator Stage 1
Selected by the European Innovation Council — one of Europe's most competitive deep-tech funding programmes.
8/10
Time & Cost Saving
CRO case study: 8/10 time savings, 9/10 cost savings, 8/10 accuracy — transforming pre-award workflows.
Client Voices
What Our Clients Say
Extremely likely to recommend · Rated by global CRO data intelligence teams
10
10 / 10
Net Promoter Score
★★★★★
Global Feasibility Director
Global CRO
Read testimonial →
★★★★★
Evaluator
European Innovation Council (EIC)
Read testimonial →
★★★★★
“
Associate Director, Data Intelligence
Global CRO
★★★★★
Past CEO
CRO (Nordics)
Read testimonial →
★★★★★
Global Feasibility Director
Global CRO
Read testimonial →
★★★★★
“
Associate Director, Data Intelligence
Global CRO
★★★★★
Evaluator
European Innovation Council (EIC)
Read testimonial →
★★★★★
Past CEO
CRO (Nordics)
Read testimonial →
How It Works
The Aurora Workflow
Four integrated steps that take you from raw RFP to proposal-ready strategy — powered by the full Aurora Suite™.
Step 01
Foundation Intelligence
Start with Trial Core™ to access 550K+ trial records, enrolment benchmarks, and investigator intelligence — building the factual foundation for every strategic decision.
→ Validated site list readyStep 02
Country & Site Strategy
Geo Matrix™ converts your feasibility inputs into ranked country strategies and competitive site positioning — delivering a proposal-ready strategy in minutes, not days.
→ Country strategy finalisedStep 03
Deep Intelligence Layer
Plume™ enriches your strategy with 50+ curated datasets — epidemiology mapping, site outreach data, startup timelines, and competitive benchmarking at global scale.
→ Intelligence package completeStep 04
Risk Modelling & Simulation
Simulator-L™ runs AI-powered projections of enrolment performance and timeline scenarios — quantifying execution risk before a single dollar of capital is committed.
→ Risk-adjusted proposal deliveredGet Started
Ready to Transform Your Workflow?
Join leading CROs using Aurora Analytica™ to compress 10-day RFP cycles into data-driven proposals delivered in hours.
The Team
Built by People Who Know Clinical Trials
Three decades of CRO experience, deep technical expertise, and a shared obsession with making clinical trial strategy smarter.
Ola Gudmundsen
Chairman30+ years in clinical research and CRO leadership. As Founder of LINK Medical Research, Ola brings unmatched expertise in trial operations, sponsor relationships, and CRO commercialisation — the strategic foundation that makes Aurora's vision possible.
View on LinkedIn
Bhavish Lekh
CEOFounder and architect of Aurora's decision intelligence platform. 10+ years leading CRO feasibility, analytics, and data-driven strategy — the expertise that shaped every module of the Aurora Suite™ from first principles.
View on LinkedIn
Espen Gudmundsen
CTO10+ years building secure, AI-driven software systems in regulated industries. Architect of scalable distributed platforms and intelligent automation frameworks — the technical force behind Aurora's enterprise-grade infrastructure.
View on LinkedInNews & Insights
Latest from Aurora Analytica
Case studies, publications, and company milestones from the team building the future of clinical trial strategy.
More Articles
PublicationApril 15, 2026
How Far Can AI Chat Agents Go With Clinical Trial Data?
AI chat agents now connect to ClinicalTrials.gov — but can they replace purpose-built feasibility tools? Co-founder Bhavish Lekh tests ChatGPT-style agents on a real 255-trial NSCLC analysis and finds the architectural limits.
Read Article →CompanyApril 2026
Why John Hillier Joining Our Advisory Board Matters
John Hillier, Head of Feasibility Strategy & Site Intelligence at Pfizer, joins the Aurora Analytica Advisory Board — bringing 25+ years of clinical trial optimisation, CRO and pharma-side feasibility leadership, and a shared vision for better decision-making in clinical development.
Read Article →CompanyMarch 2026
The Story Behind Aurora Analytica
After a decade leading feasibility operations across 400+ clinical studies, Co-founder & CEO Bhavish Lekh shares the journey from idea to platform — and what's next for Aurora Analytica.
Read Article →CompanyNovember 2025
Aurora Analytica Welcomes Espen Gudmundsen as CTO
Espen Gudmundsen joins Aurora Analytica as Chief Technology Officer, bringing 10+ years of expertise in software development, AI, and cybersecurity.
Read Article →CompanyOctober 2025
Aurora Analytica Awarded 1.2 Million NOK in Innovation Grants from Innovation Norway
Aurora Analytica™ has received a total of 1.2 million NOK in grants from Innovation Norway since 2024, accelerating development of the Aurora Suite™.
Read Article →PublicationAugust 2025
Breaking Down Silos: A User-Defined Approach to Global Feasibility
How Aurora Analytica™ transforms fragmented data into connected, actionable clinical trial intelligence — going beyond siloed databases.
Read Article →PublicationAugust 2025
Decision Engines™ vs Data Tools: Navigating Clinical Trials Smarter
Why a GPS beats hundreds of paper maps — exploring the difference between traditional data tools and Aurora's Decision Engines™.
Read Article →CompanyMarch 2025
Aurora Analytica Recognized by the EIC for Its Ground-breaking Innovation
The European Innovation Council described the Aurora Suite as "a superior solution compared to existing fragmented systems" and a "highly novel, deep tech breakthrough."
Read Article →CompanyMarch 2025
Aurora Analytica Awarded Innovation Norway Start-up 2 Grant
Aurora Analytica has been awarded the prestigious Start-up 2 grant from Innovation Norway, validating our technology and mission.
Read Article →Case StudyMarch 2025
Delivering New Clinical Trial Wins for CROs
We supported a mid-size CRO through a full feasibility and strategy process, resulting in a won global clinical trial and an NPS of 9.1.
Read Article →PublicationSep 2024
Optimizing Phase III Trials in Pancreatic Cancer – ESMO Poster 2024
Our ESMO 2024 poster showcases how the Aurora Suite™ optimizes Phase III trial strategy in pancreatic cancer — delivering 200%+ enrolment improvement and 80%+ time savings.
Read Article →PublicationApril 15, 2026
How Far Can AI Chat Agents Go With Clinical Trial Data?
AI chat agents now connect to ClinicalTrials.gov — but can they replace purpose-built feasibility tools? Co-founder Bhavish Lekh tests ChatGPT-style agents on a real 255-trial NSCLC analysis and finds the architectural limits.
Read Article →CompanyApril 2026
Why John Hillier Joining Our Advisory Board Matters
John Hillier, Head of Feasibility Strategy & Site Intelligence at Pfizer, joins the Aurora Analytica Advisory Board — bringing 25+ years of clinical trial optimisation, CRO and pharma-side feasibility leadership, and a shared vision for better decision-making in clinical development.
Read Article →CompanyMarch 2026
The Story Behind Aurora Analytica
After a decade leading feasibility operations across 400+ clinical studies, Co-founder & CEO Bhavish Lekh shares the journey from idea to platform — and what's next for Aurora Analytica.
Read Article →CompanyNovember 2025
Aurora Analytica Welcomes Espen Gudmundsen as CTO
Espen Gudmundsen joins Aurora Analytica as Chief Technology Officer, bringing 10+ years of expertise in software development, AI, and cybersecurity.
Read Article →CompanyOctober 2025
Aurora Analytica Awarded 1.2 Million NOK in Innovation Grants from Innovation Norway
Aurora Analytica™ has received a total of 1.2 million NOK in grants from Innovation Norway since 2024, accelerating development of the Aurora Suite™.
Read Article →PublicationAugust 2025
Breaking Down Silos: A User-Defined Approach to Global Feasibility
How Aurora Analytica™ transforms fragmented data into connected, actionable clinical trial intelligence — going beyond siloed databases.
Read Article →PublicationAugust 2025
Decision Engines™ vs Data Tools: Navigating Clinical Trials Smarter
Why a GPS beats hundreds of paper maps — exploring the difference between traditional data tools and Aurora's Decision Engines™.
Read Article →CompanyMarch 2025
Aurora Analytica Recognized by the EIC for Its Ground-breaking Innovation
The European Innovation Council described the Aurora Suite as "a superior solution compared to existing fragmented systems" and a "highly novel, deep tech breakthrough."
Read Article →CompanyMarch 2025
Aurora Analytica Awarded Innovation Norway Start-up 2 Grant
Aurora Analytica has been awarded the prestigious Start-up 2 grant from Innovation Norway, validating our technology and mission.
Read Article →Case StudyMarch 2025
Delivering New Clinical Trial Wins for CROs
We supported a mid-size CRO through a full feasibility and strategy process, resulting in a won global clinical trial and an NPS of 9.1.
Read Article →PublicationSep 2024
Optimizing Phase III Trials in Pancreatic Cancer – ESMO Poster 2024
Our ESMO 2024 poster showcases how the Aurora Suite™ optimizes Phase III trial strategy in pancreatic cancer — delivering 200%+ enrolment improvement and 80%+ time savings.
Read Article →Contact
Get In Touch
Let's talk about your clinical trial strategy
Whether you're a CRO looking to modernise feasibility workflows or a pharma sponsor seeking smarter site selection — we're here to help.
info@aurora-analytica.com
Location
Oslo, Norway
EIC Accelerator
Stage 1 Selected
ESMO Published
Leading Oncology Conference
10/10 NPS
Global CRO Case Study